A protein interaction map identifies existing drugs targeting SARS-CoV-2

A protein interaction map identifies existing drugs targeting SARS-CoV-2

Abstract Background Severe acute respiratory syndrome coronavirus (SARS-CoV-2), an emerging Betacoronavirus, is the causative agent of COVID-19. Angiotensin converting enzyme 2 (ACE2), being the main cell receptor of SARS-CoV-2, plays a role in the entry of the virus into the cell. Currently, there...

Full description

Bibliographic Details
Main Authors: Claudia Cava, Gloria Bertoli, Isabella Castiglioni
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Pharmacology and Toxicology
Subjects:
COVID-19
SARS-CoV-2
Drug
Network
In silico analysis
Molecular docking
Online Access:http://link.springer.com/article/10.1186/s40360-020-00444-z

Internet

http://link.springer.com/article/10.1186/s40360-020-00444-z

Similar Items